Sentences with phrase «from diabetic ketoacidosis»

Note: Being in a state of nutritional ketosis is safe and differs from diabetic ketoacidosis, a life - threatening complication of diabetes that occurs when the body produces very high levels of ketones in response to a lack of insulin.

Not exact matches

Some patients, the lawsuit said, intentionally allowed themselves to slip into diabetic ketoacidosis — a blood syndrome that can be fatal — to get insulin from hospital emergency rooms.

They are an absolutely normal part of human energy metabolism that preferentially fuel the brain while much of the rest of the body runs on fatty acids during times of carbohydrate unavailability.50 The negative view of KBs stems from confusion of benign dietary ketosis (BDK) and diabetic ketoacidosis (DKA).

The misconception about treating T1D with a KD comes from the confusion between nutritional ketosis (NK) and diabetic ketoacidosis (DKA).

We would like to emphasize that ketosis is a completely physiological mechanism and it was the biochemist Hans Krebs who first referred to physiological ketosis to differentiate it from the pathological keto acidosis seen in type 1 diabetes.8 In physiological ketosis (which occurs during very - low - calorie ketogenic diets), ketonemia reaches maximum levels of 7/8 mmol / l (it does not go higher precisely because the CNS efficiently uses these molecules for energy in place of glucose) and with no change in pH, whereas in uncontrolled diabetic ketoacidosis it can exceed 20 mmol / l with a concomitant lowering of blood pH9, 10 (Table 1).

In addition to diabetic ketoacidosis, there are some other complications which can result from uncontrolled diabetes in dogs.

In fact, there are a number of serious complications that can result from canine diabetes — one of them is called diabetic ketoacidosis (DKA).

Metabolic acidosis is a mild condition resulting from increased acid production from metabolism or reduced excretion of stomach acids that could be caused by underlying conditions like diabetic ketoacidosis, renal failure, or respiratory dysfunction.

Although the FDA issued a drug safety communication warning about the Invokana diabetic ketoacidosis risk in May 2015, the FDA has not recalled the drug from the market.

The FDA identified 20 cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients treated with SGLT2 inhibitors from March 2013 to June 6, 2014.

Although not part of this cross-sectional study we observed that 3 of the 76 children died during the observation period (2 children from presumed hypoglycemia and 1 from presumed diabetic ketoacidosis).